Muscle RelaxantsThe Monographs in Anaesthesiology series is designed to enable the anaesthetist, and others in the health services field, to stay abreast of the changing trends, advances and innovations associated with the research and developments in this clinical discipline. This monograph is devoted to neuromuscular blocking agents. It reviews the present state of receptor research, pharmacokinetic modelling, monitoring, analytical technology and clinical use of the neuromuscular blocking agents. Clinicians, scientists engaged in fundamental or applied research and students at the start of clinical or research training should find this volume of particular use. |
From inside the book
Results 1-3 of 56
Page 168
... onset time of the non - depolarising block is longer and more unpredictable than the onset time following suxamethonium at 1 mg / kg . Rapid sequence induction When rapid tracheal intubation must be achieved to prevent pulmonary aspira ...
... onset time of the non - depolarising block is longer and more unpredictable than the onset time following suxamethonium at 1 mg / kg . Rapid sequence induction When rapid tracheal intubation must be achieved to prevent pulmonary aspira ...
Page 169
... onset time of vecuronium blockade can be achieved by exceeding 0.15 mg / kg ( three times ED90 ) [ 9,40 ] . Even at that dose level of vecuronium the onset of 100 % depression of twitch tension is still significantly longer than that ...
... onset time of vecuronium blockade can be achieved by exceeding 0.15 mg / kg ( three times ED90 ) [ 9,40 ] . Even at that dose level of vecuronium the onset of 100 % depression of twitch tension is still significantly longer than that ...
Page 506
... onset times and durations of ac- tion of the antagonist have been determined by maintaining a stable plasma con- centration of d - tubocurarine . When this technique is utilized , then the only factor responsible for antagonism of ...
... onset times and durations of ac- tion of the antagonist have been determined by maintaining a stable plasma con- centration of d - tubocurarine . When this technique is utilized , then the only factor responsible for antagonism of ...
Contents
The nicotinic acetylcholine receptor | 19 |
Chemical structures of neuromuscular blocking agents | 59 |
Some aspects of the physiology pharmacology and immunobiology of | 87 |
Copyright | |
13 other sections not shown
Common terms and phrases
AChR administration agonist Agoston Anaesth anaesthesia anaesthetic Analg Anesthesiology antagonism antagonists antibodies atracurium binding Biol blockade blood bromide cardiac cardiovascular choline clearance Clin clinical compounds curare d-tubocurarine decreased depolarizing disease drug concentration duration of action edrophonium effect elimination endplate excretion fazadinium function gallamine halothane hepatic histamine release HPLC increased infants infusion inhibition injection interaction intubation kinetics laudanosine liver Maelicke mechanism membrane metabolites method metocurine mg/kg Miller muscle relaxants muscular myasthenia gravis nAChR neonates neostigmine nerve stimulation neuro neuromuscular blocking agents neuromuscular blocking drugs neuromuscular junction neuromuscular transmission nicotinic acetylcholine receptor NMBA nondepolarizing onset pancuronium paralysis patients with renal pharmacokinetics Pharmacokinetics and pharmacodynamics Pharmacol pharmacology Physiol pipecuronium plasma concentration potency potential produce prolonged protein pyridostigmine recovery renal failure respiratory response sensitivity serum skeletal muscle structure studies subunits succinylcholine surgery suxamethonium tion tissue Torpedo train-of-four twitch vecuronium Viby-Mogensen volume of distribution Waud µg/l